Selecting Targeted Treatment For Patients With Uncontrolled, Moderate To Severe Asthma

Selecting Targeted Treatment for Patients With Uncontrolled, Moderate to Severe Asthma

Uncontrolled, Moderate to Severe Asthma: Identifying Eligible Patients for Targeted Biologic Therapy

Improving Outcomes in Uncontrolled Moderate-to-Severe Asthma: Right Treatment for the Right Patient

Severe Asthma: Directing New Treatment Approaches at the Airway Epithelium

Managing Severe Asthma: Strategies for Selecting Novel Treatments and Improving Adherence

Targeted Treatment in Severe Asthma: Moving Toward Precision Medicine

Treating Asthma Using Biologic Therapy

The France Foundation

Episode 3: Uncontrolled Moderate to Severe Asthma inPediatric and Adult Patients Around the World

Assessing, Managing, and Engaging Patients With Uncontrolled Asthma: Approaches Around the World

Advances in the Treatment of Uncontrolled Persistent Asthma: Insights in Personalizing Patient Care

Webinar: Biologic Therapy for Patients with Severe Asthma

Uncontrolled vs. Severe Asthma

American Lung Association

Take a Deep Breath: How to Treat Severe Asthma

The France Foundation

Treating Uncontrolled Asthma

Expert Insights on the Rationale for Targeting Epithelial Alarmins in Severe Asthma

Dupilumab efficacy in adolescents with uncontrolled, moderate‐to‐severe asthma: LIBERTY ASTHMA QUEST

Biologic Treatment Selection in Severe Asthma: Questions & Answers

Defining Severe Asthma & Recommendations for the Use of Biologics

Finding the Path to Improved Outcomes in Uncontrolled Persistent Asthma

Improving the Management of CRS/NP: Selecting the Right Patients for Targeted Treatment